Related Experiment Video
Updated: Jul 31, 2026

05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Vascular effects on ciliary tissue from endoscopic versus trans-scleral cyclophotocoagulation
1Department of Ophthalmology, University of California, San Francisco, 10 Koret Way, San Francisco, CA 94143, USA. lins@vision.ucsf.edu
The British Journal of Ophthalmology
|March 21, 2006
Summary
Trans-scleral cyclophotocoagulation (TCP) causes longer-lasting vascular occlusion than endoscopic cyclophotocoagulation (ECP), potentially explaining differences in efficacy and complications for glaucoma treatment.
Area of Science:
- Ophthalmology
- Vascular Biology
- Surgical Innovation
Background:
- Glaucoma treatment often involves procedures to reduce intraocular pressure.
- Cyclophotocoagulation, including ECP and TCP, targets the ciliary body's vasculature.
- Understanding the vascular effects of these treatments is crucial for optimizing patient outcomes.
Purpose of the Study:
- To compare the acute and chronic vascular effects of ECP and TCP.
- To investigate the impact of these vascular changes on ciliary body perfusion.
- To correlate vascular effects with clinical efficacy and complications.
Main Methods:
- Rabbit models underwent unilateral ECP or TCP.
- Endoscopic fluorescein angiography assessed ciliary process perfusion at multiple time points.
- Histopathology confirmed vascular occlusion.
- NIH Image software quantified perfusion intensity.
Main Results:
- Both ECP and TCP initially reduced blood flow.
- TCP resulted in sustained non-perfusion at 1 week and 1 month.
- ECP showed partial reperfusion by 1 week and significant reperfusion by 1 month.
- Histopathology indicated greater vascular occlusion with TCP.
Conclusions:
- Chronic poor perfusion after TCP may contribute to its efficacy and complications like hypotony.
- Late reperfusion following ECP might explain differing efficacy and complication rates compared to TCP.
- These findings offer insights into the mechanisms underlying cyclophotocoagulation treatments.

